Supporting appropriate antibiotic use in community and aged care

Treating viral infections with antibiotics is one of the biggest drivers of increasing antimicrobial resistance. But pharmacists are helping to curb overuse.

Antimicrobial resistance (AMR) in Australia continues to increase despite wide-ranging efforts to control it. Each year, hundreds of Australians die due to antibiotic-resistant infections.1

In 2024, 23.2 million antibiotic prescriptions were supplied to about 37.1% of Australians under the Pharmaceutical Benefits Scheme – a 4.8% increase on the previous year.2

Those figures were highlighted in the sixth AURA (Antimicrobial Use and Resistance in Australia) report, released in February. It’s the first national AMR report from the Australian Centre for Disease Control, established on 1 January 2026, and forms a foundational part of Australia’s long-term response to AMR.

Drawing on data from hospitals, residential aged care facilities (RACFs) and the community, the AURA report found critical antimicrobial resistance rose by 25% in 2024. Fewer than half (45%) of antibiotics given after surgery were deemed appropriate.2

On the upside, antibiotic use was 21% lower than in 2015, and 88% of ‘last-line’ antibiotics, used to treat life-threatening infections, were still ‘prescribed appropriately’ in hospitals.2 But key areas of concern remain.

Coughs, colds and kids

Prescribing for acute respiratory infections often goes further than guidelines recommend. A 2025 study of Australian early-career GPs found antibiotics were prescribed for 36.2% of acute respiratory tract infections, rising to 74.1% of acute bronchitis cases – despite antibiotics generally not being indicated for the condition.3

Prescribing in children remains another key focus. Between 2013 and 2023, the proportion of Australian children under 13 dispensed at least one antibiotic each year fell from 45.7% to 33.6%, while prescriptions dropped from 103 to 63 per 100 children. Use of broader-spectrum ‘Watch’ antibiotics also fell by an average of 15% a year.4 But in 2024, there were still 716 antimicrobial prescriptions per 1,000 children aged 0–4.5

Often the reasons for prescribing go beyond the infection itself. A 2025 study in Sydney’s Fairfield area, a lower-income, culturally and linguistically diverse community, found two factors driving demand for antibiotics in young children. Parents believed antibiotics could treat conditions that don’t respond to them, and felt pressure from work to get their child back into childcare quickly. Some said they would see multiple doctors if they were refused antibiotics.6

Victorian consultant pharmacist Dr Jenny Gowan FPS echoes this, saying doctors report pressure from patients to prescribe antibiotics for upper respiratory tract infections, even when the infection may be viral rather than bacterial.

Working within the limits

Dr Gowan says pharmacists are at a disadvantage because they can’t order pathology tests. When a patient has an upper respiratory tract infection, the pharmacist’s role is to refer them to a medical practitioner if an antibiotic may be needed, or to guide them through self-care. Good history taking is also key to identifying comorbidities.

But PSA has protocols to provide pharmacists with a structured, evidence-based framework for assessing and managing infections within their scope – including for pharmacists who have undergone training to assess and treat uncomplicated urinary tract infections (UTIs).

‘The PSA Treatment Guidelines for Pharmacists – Cystitis provides pharmacists with guidance for managing uncomplicated UTIs in women aged 18–65 years with an anatomically normal urinary tract and low risk of complications,’ Dr Gowan says. ‘The protocol aligns with national clinical guidelines, professional practice standards and evidence-based resources such as Therapeutic Guidelines, the Australian Medicines Handbook.’

The aged care picture

Progress on prescribing in the community hasn’t reached aged care. In 2024, 14.4% more antimicrobials – antibiotics, antivirals, antifungals, and antiparasitic agents – were prescribed to older Australians in RACFs than in 2023. And 34.7% of antibiotics prescribed to residents in RACFs were used for over 6 months.2

Diagnosing UTIs is harder in RACFs, where many residents have dementia.

‘Usually nursing staff notice a sudden change in behaviour – confusion, agitation, possible temperature – and then apply the clinical pathway algorithm for suspected UTIs developed by the Aged Care Quality and Safety Commission,’ Dr Gowan says.

Staff report this to the medical practitioner, who will order a mid-stream urine (MSU) test if possible.

‘Many residents are incontinent and wear pads. Because of patient distress and pressure from families, GPs will often prescribe antibiotics without waiting for results,’ she says. ‘Dipstick testing is no longer recommended due to the high proportion of older people who have bacteria in the urine normally.’

To beat AMR, health professionals, including pharmacists, need to work as a team, Dr Gowan says. Here’s how two pharmacists are countering it on the ground.

Case 1

Dr Jenny Gowan FPS

Consultant pharmacist, Eltham, VIC

Mrs GT, a 92-year-old aged care resident, has multiple comorbidities – including hypertension, hypothyroidism, vertigo, dementia with moderate cognitive impairment (MMSE 18/30) and double incontinence. She also has a pacemaker. Mrs GT required a Residential Medication Management Review (RMMR).

Her current medicines were:

  • atorvastatin 20 mg once daily in the morning
  • colecalciferol 1,000 IU once daily in the morning
  • donepezil 10 mg once daily in the morning
  • levothyroxine 100 micrograms once daily in the morning, plus 50 micrograms in the morning Monday to Friday.

She takes the following medicines when necessary:

  • docusate with senna 2 tablets twice daily
  • oral rehydration sachets 1 sachet every 2 hours
  • loperamide 2 mg 1–2 tablets three times daily
  • metoclopramide 10 mg 1 tablet three times daily
  • oxycodone 5 mg 1–2 tablets every 4 hours
  • paracetamol 500 mg 1–2 tablets three times daily.

Mrs GT uses a four-wheel walker and can walk up to only 50 m at a time. She has a history of 3–4 UTIs per year.

At the RMMR, she had symptoms of a UTI with confusion – agitation and general deterioration. The next of kin refused an MSU or a course of trimethoprim for 7 days that her doctor had advised.

A week later, her family requested prophylactic cefalexin for 6 months, 250 mg once daily in the morning, which the GP prescribed.

Without an MSU, the bacteria causing her infection were never identified, and there’s a high chance they are resistant to cefalexin. This increases the risk of antibacterial resistance with doubtful gain in UTI reduction. Continuous prophylaxis for 6 months may be warranted in patients experiencing recurrent, symptomatic infections but should be closely reviewed.

I documented the indication, dose and planned duration, and recorded the need for ongoing treatment to be reassessed regularly based on Mrs GT’s symptoms. A urine sample should be sent for culture only if a new infection is suspected.

I also suggested measures to prevent recurrent infection, including more frequent pad changing, washing and drying the affected area, and increased fluid intake to dilute the urine.

Residents are frequently dehydrated and sometimes they don’t know they are thirsty. They must be given water regularly, but within their individual fluid limits. Some residents may be on fluid restriction due to oedema.

Case 2

Priyanka Satpati

Community pharmacist, Sydney, NSW

A 7-year-old child, accompanied by their parent, presented after several days of mild, improving cough, low-grade fever (approximately 37.5 °C), sore throat and runny nose.

They reported no breathing difficulty or wheezing. Appetite was reduced, but fluid intake and urination were normal. The child remained active and alert. They had no significant medical history and were not on any regular medications. Immunisation was up to date.

The parent was concerned their child’s symptoms hadn’t cleared and asked whether they needed to see a GP for antibiotics.

Supportive care included honey and lemon in warm water, Vicks VapoRub and a cool-mist humidifier. Paracetamol was given as needed during the first 2 days for relief of discomfort from a sore throat and mild fever.

I explained that the clinical presentation was most consistent with a viral upper respiratory tract infection, for which antibiotics are not indicated. The cough, runny nose, sore throat and improving low-grade fever, alongside normal hydration and activity, did not suggest bacterial infection or serious illness. There was also no breathing difficulty.

I suggested the additional care advice:

  • saline nasal spray, 1–2 sprays in each nostril as needed for congestion and runny nose
  • regular fluids and adequate rest
  • warm fluids and honey
  • paracetamol for discomfort, according to age/weight and product directions.
  • The parent was advised that symptoms may persist for several days.

Safety-netting advice included seeking urgent medical help for breathing difficulty, wheeze, poor fluid intake or reduced urination, high or persistent fever, unusual drowsiness or significant worsening.

The parent was reassured that the illness was likely self-limiting and antibiotics were not indicated. They were advised to continue supportive care and seek medical review if symptoms worsened.

References

  1. Australian Commission on Safety and Quality in Health Care. Antimicrobial use and resistance in Australia (AURA). 2026. At: https://www.safetyandquality.gov.au/clinical-topics/antimicrobial-use-and-resistance-australia-aura
  2. Australian Centre for Disease Control. Sixth Australian report on antimicrobial use and resistance in human health (AURA report). 2026. At: https://www.amr.gov.au/resources/sixth-australian-report-antimicrobial-use-and-resistance-human-health-aura-report-0
  3. Turner A, van Driel ML, Mitchell B, et al. Interpractice variability in antibiotic prescribing for acute respiratory tract infections: a cross-sectional study of Australian early-career general practitioners. BMJ Open. 2025;15(8):e094811.
  4. Kelty E, Tairy E, Sims S, et al. Changes in the dispensing of antibiotics to Australian children between 2013 and 2023: are we heading in the right direction? Paediatr Perinat Epidemiol. 2026;40(3):342–8.
  5. Australian Commission on Safety and Quality in Health Care. Antimicrobial use in the community: 2024. At: https://www.safetyandquality.gov.au/resources/antimicrobial-use-community-2024
  6. Knight AW, Hasan I, Tam CWM, et al. A qualitative study of the influence of childcare on high antibiotic use in a multicultural, lower socioeconomic community. BMC Public Health. 2025;25:1732.